Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

cations or interruption for severe or persistent elevations. In Study 1, seventeen (5.7%) patients treated with Exjade developed elevations in SGPT/ALT levels >5 times the upper limit of normal at 2 consecutive visits versus five (1.7%) patients treated with deferoxamine.

Serious hypersensitivity reactions (such as anaphylaxis and angioedema) have been reported in patients receiving Exjade, with the onset of the reaction occurring in the majority of cases within the first month of treatment. If reactions are severe, discontinue Exjade and institute appropriate medical intervention.

Skin rashes may occur during treatment with Exjade. For rashes of mild to moderate severity, Exjade may be continued without dose adjustment, since the rash often resolves spontaneously. In severe cases, Exjade may be interrupted. Reintroduction at a lower dose with escalation may be considered in combination with a short period of oral steroid administration.

Auditory (high-frequency hearing loss, decreased hearing) and ocular (lens opacities, cataracts, elevations in intraocular pressure and retinal disorders) disturbances have been reported with Exjade therapy in less than 1% of patients in clinical trials. Auditory and ophthalmic testing (including slit lamp examinations and dilated fundoscopy) are recommended before the start of Exjade treatment and thereafter at regular intervals (every 12 months). If disturbances are noted, consider dose reduction or interruption.

Gastrointestinal (GI) irritation may occur during Exjade treatment. Upper GI ulceration and hemorrhage have been reported in patients, including children and adolescents, receiving Exjade. Physicians and patients should remain alert for signs and symptoms of GI ulceration and hemorrhage and promptly initiate additional evaluation and treatment if a serious GI adverse event is suspected. Use caution when administering Exjade in combinat
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... New York Times article ... Division," illustrates an internal renal community reimbursement debate ... be deprived of their life-saving immunosuppressive medications beyond ... Congress is poised to approve this urgent transplant ... kidney recipients, behind-the-scenes debate continues within the renal ...
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Systemic ... and Market Forecasts to 2015 ... Systemic Lupus Erythematosus - Drug Pipeline ... ,, Summary ,, GlobalData, ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...
Breaking Medicine Technology:AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 1New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 2New Productivity Suite From Varian Inc Increases Throughput for NMR Laboratories 14169 3King Announces Commercial Availability of EMBEDA 28TM 29 57735 1King Announces Commercial Availability of EMBEDA 28TM 29 57735 2King Announces Commercial Availability of EMBEDA 28TM 29 57735 3King Announces Commercial Availability of EMBEDA 28TM 29 57735 4King Announces Commercial Availability of EMBEDA 28TM 29 57735 5King Announces Commercial Availability of EMBEDA 28TM 29 57735 6King Announces Commercial Availability of EMBEDA 28TM 29 57735 7King Announces Commercial Availability of EMBEDA 28TM 29 57735 8King Announces Commercial Availability of EMBEDA 28TM 29 57735 9King Announces Commercial Availability of EMBEDA 28TM 29 57735 10King Announces Commercial Availability of EMBEDA 28TM 29 57735 11AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 1AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 2AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS 112 in Cancer 14165 3
... Presented at the 31st European Cystic Fibrosis Conference ... Republic, June 12 /PRNewswire/,-- PTC Therapeutics, Inc. (PTC) ... PTC124 in cystic fibrosis (CF). Results from an ... oral PTC124 treatment in adult,patients with nonsense-mutation-mediated CF ...
... June 12 Cardiogenesis,Corporation (Pink Sheets: CGCP), ... revascularization, today announced a scientific presentation,that describes ... combining,transmyocardial revascularization (TMR) with autologous bone marrow ... Revascularization Combined,with Concentrated Autologous Stem Cells," is ...
Other Medicine Technology:PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 2PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 3PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 4PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity 5Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells 2Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells 3Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells 4
(Date:12/15/2009)... leptin associated with lower dementia risk, research finds , , ... of leptin, a hormone that regulates appetite, may guard ... 10 or 15 years this may be one of ... of Alzheimer,s disease," said senior study author Dr. Sudha ... School of Medicine. "Or it may be one of ...
(Date:12/15/2009)... delivered ,, WASHINGTON, Dec. 15 ... that healthcare reform does not override the prostate ... in 37 states. ,, Prostate cancer screening is ... and individuals who are identifiable as high risk, ... a family history of prostate cancer. The American ...
(Date:12/15/2009)... N.Y., Dec. 15 Team In Training ... charity sports training program, has reached ... support blood cancer research and patient services. ,, ... the pre-eminent charity endurance sports training program, preparing ... half marathon, triathlon, 100-mile century cycle ride or ...
(Date:12/15/2009)... BRAINTREE, Mass., Dec. 15 North American ... +3.9% in November year-over-year, according to the ... life insurance applications over the past three months ... 2009 levels of -1.6%, to flat at November,s ... recovering their interest in the benefits available from ...
(Date:12/15/2009)... service, such as tutoring children, can help older ... to a study led by researchers at the ... functional magnetic resonance imaging (fMRI), the researchers found ... made gains in key brain regions that support ... daily life. The study is the first of ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:For older adults, participating in social service activities can improve brain functions 2
... this deadly disease, researchers say , , WEDNESDAY, Dec. 17 (HealthDay ... of either of two enzymes associated with their tumors tended ... of one of the two enzymes, new research shows. , ... of both proteins. , "If there were low levels [of ...
... 17 Women who struggle,achieving sexual satisfaction can now get a ... and frustrating to find for others. Most women have the ... spot. Because,female orgasm is not required for reproduction, as well ... was not discussed until,recently. , ...
... Dec. 17 Sutter Health has announced,the appointment of ... will assume her new role January 5, 2009, succeeding ... Formerly senior partner of ... (HRDE) for the past two decades, DiBenedetto,served for more ...
... is proud to announce they have teamed up with Cheryl Burke of ... set to dance hits of the ,70s, Cheryl Burke presents DISCO ... Burke has been dancing since the age of 4 and over the ... For the past six television seasons, the two-time champion of "Dancing with ...
... are becoming aware of the prevalence of mental health ... equipped are we to help the many people who ... December issue of the Canadian Journal of Psychiatry ... mental health and substance use services to adequately address ...
... Dec. 17 Women are built differently,than men. That,s why ... the nation,s first mattress specifically for women. , ... intuitively recognizes the,difference between straight lines and curves," says FloBeds ... things being equal, a woman usually needs a softer mattress ...
Other Medicine News:Health News:Low Levels of 2 Enzymes in Ovarian Cancer Cells Shortened Survival 2Health News:Know Your G Spot 2Health News:Sutter Health Welcomes New General Counsel 2Health News:Cheryl Burke of 'Dancing with the Stars' Joins Forces With Time Life To Create a Brand New Dance Workout, 'DISCO ABS' 2Health News:Cheryl Burke of 'Dancing with the Stars' Joins Forces With Time Life To Create a Brand New Dance Workout, 'DISCO ABS' 3Health News:National rates of co-occurring substance use and mental disorders call for better service integration 2Health News:National rates of co-occurring substance use and mental disorders call for better service integration 3Health News:FloBeds Develops Nation's First 'For Women Only' Mattress 2
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
A system for the removal and filtration of laser and surgical smoke....
The FreedomAire Surgical Helmet System is a lightweight, comfortable helmut system with superior air flow, and a removable motor module that lifts off for easy cleaning....
...
Medicine Products: